Abivax (ABVX) Change in Cash (2024 - 2026)
Abivax (ABVX) posted quarterly Change in Cash of -$46.0 million for Q1 2026, down 7.51% year-over-year from -$49.7 million in Q1 2025, and up 45.89% quarter-over-quarter from -$85.0 million in Q4 2025.
Abivax (ABVX) Change in Cash (2024 - 2026) Analysis & Trends
Abivax's Change in Cash history runs 3 years deep, the most recent figure standing at -$46.0 million for Q1 2026.
- In Q1 2026, Change in Cash fell 7.51% year-over-year to -$46.0 million; the TTM figure through Mar 2026 stood at $439.0 million (up 396.2% YoY), while the FY2025 annual figure was $433.6 million, up 476.76% from the prior year.
- Change in Cash for Q1 2026 stood at -$46.0 million, up from -$85.0 million in the prior quarter.
- The five-year high for Change in Cash was $618.1 million in Q3 2025, with the low at -$85.0 million in Q4 2025.
- The 3-year median for Change in Cash is -$42.8 million (2025), against an average of $31.1 million.
- Peak annual rise in Change in Cash reached 1444.43% in 2025, while the deepest fall reached 280.84% in 2025.
- Abivax's Change in Cash stood at -$38.7 million in 2024, then slumped by 119.56% to -$85.0 million in 2025, then jumped by 45.89% to -$46.0 million in 2026.
- Business Quant data shows ABVX's Change in Cash at -$46.0 million in Q1 2026, -$85.0 million in Q4 2025, and $618.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Abivax | 9.39 Bn | 9.39 Bn | - | -45.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.97 Mn |
| Dec 31, 2025 | -84.95 Mn |
| Sep 30, 2025 | 618.14 Mn |
| Jun 30, 2025 | -48.25 Mn |
| Mar 31, 2025 | -42.75 Mn |
| Dec 31, 2024 | -38.69 Mn |
| Sep 30, 2024 | -45.98 Mn |
| Jun 30, 2024 | -20.77 Mn |
| Mar 31, 2024 | -11.23 Mn |